Biodexa Pharmaceuticals Plc
BDRX· Nasdaq
Biodexa Pharmaceuticals Plc
- Last sale
- Oct 2, 2026 · -10.68%
- Market cap
- $1.31M
- 2.26M shares
- Filings
- 721
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | £381,000 | reported | |
| FY 2022 | 2022-12-31 | £699,000 | reported | |
| FY 2021 | 2021-12-31 | £578,000 | reported | |
| FY 2020 | 2020-12-31 | £343,000 | reported | |
| FY 2019 | 2019-12-31 | £674,000 | reported | |
| FY 2018 | 2018-12-31 | £1,938,000 | reported | |
| FY 2017 | 2017-12-31 | £989,000 revised | reported | |
| FY 2016 | 2016-12-31 | £1,323,000 revised | reported | |
| FY 2015 | 2015-12-31 | £1,375,000 | reported |
Biodexa Pharmaceuticals Plc · CIK 1643918 · Engraved from SEC EDGAR
